MiNK Therapeutics (INKT) Stock Chart & Stock Price History → Top 5 Tech Stocks to Buy for 2024 (From Daily Market Alerts) (Ad) Free INKT Stock Alerts $0.96 -0.02 (-2.03%) (As of 06/7/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MiNK Therapeutics Stock Price Performance5 Day Performance-3.08%1 Month Performance+3.68%3 Month Performance+0.23%6 Month Performance-5.47%Year-To-Date Performance-9.88%1 Year Performance-56.95% Receive INKT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyThe new masters of energyAccording to one source, this new grid could soon provide energy to “one billion people in the world who don’t have access to electricity right now.” And early investors could make a fortune.Click here to get all the details. INKT Stock Chart for Saturday, June, 8, 2024 INKT Chart by TradingView MiNK Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$0.98$0.96-1.61%$1.00$0.9545,973 shs$33.49 million06/06/2024$1.00$0.98-2.00%$1.00$0.9640,803 shs$34.04 million06/05/2024$1.00$1.00+0.49%$1.00$0.9651,374 shs$34.73 million06/04/2024$0.99$1.00+0.02%$1.00$0.9545,909 shs$34.56 million06/03/2024$0.97$0.99+2.57%$1.02$0.85162,417 shs$34.55 million05/31/2024$0.96$0.97+1.04%$0.98$0.9432,245 shs$33.69 million Get the Latest News and Ratings for INKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$0.97$0.96-0.91%$0.98$0.9322,706 shs$33.34 million05/29/2024$0.94$0.97+3.06%$0.97$0.9313,621 shs$33.65 million05/28/2024$0.96$0.94-2.09%$0.98$0.93181,310 shs$32.65 million05/27/2024$0.96$0.96+0.01%$1.02$0.9547,500 shs$33.34 million05/24/2024$0.99$0.96-2.53%$1.02$0.9544,798 shs$33.34 million05/23/2024$1.00$0.99-1.50%$1.02$0.9789,784 shs$34.21 million05/22/2024$0.99$1.00+1.01%$1.01$0.9487,864 shs$34.73 million05/21/2024$1.01$0.99-1.98%$1.02$0.9828,143 shs$34.38 million05/20/2024$1.01$1.01$1.05$1.0028,114 shs$35.08 million05/17/2024$1.04$1.01-2.88%$1.04$0.9868,762 shs$35.08 million05/16/2024$1.04$1.04$1.10$0.9876,498 shs$36.09 million05/15/2024$1.12$1.04-7.14%$1.30$0.93560,202 shs$36.09 million05/14/2024$0.98$1.12+14.31%$1.16$0.98625,100 shs$38.86 million05/13/2024$0.90$0.98+8.87%$1.08$0.954.58 million shs$34.00 million05/10/2024$0.91$0.90-1.25%$0.92$0.8920,100 shs$31.23 million05/09/2024$0.93$0.91-2.00%$0.93$0.86135,734 shs$31.63 million05/08/2024$0.93$0.93-0.01%$0.95$0.9218,971 shs$32.27 million05/07/2024$0.94$0.93-1.13%$0.97$0.9258,814 shs$32.27 million05/06/2024$0.98$0.94-4.01%$1.01$0.94118,587 shs$32.64 million05/03/2024$0.97$0.98+1.09%$0.99$0.9428,781 shs$34.01 million05/02/2024$0.95$0.97+1.77%$0.97$0.9240,059 shs$33.64 million05/01/2024$0.99$0.95-3.79%$0.99$0.9379,937 shs$33.05 million04/30/2024$0.95$0.99+4.20%$0.99$0.9333,909 shs$34.35 million04/29/2024$0.93$0.95+2.44%$0.98$0.9158,163 shs$32.97 million04/26/2024$0.87$0.93+6.46%$0.93$0.8832,348 shs$32.18 million04/25/2024$0.89$0.87-2.00%$0.92$0.8638,201 shs$30.23 million04/24/2024$0.87$0.89+2.07%$0.93$0.8637,583 shs$30.85 million04/23/2024$0.89$0.87-2.57%$0.93$0.8792,040 shs$30.22 million04/22/2024$0.88$0.89+2.02%$0.91$0.8639,998 shs$31.02 million04/19/2024$0.87$0.88+0.53%$0.90$0.8640,310 shs$30.41 million04/18/2024$0.92$0.87-4.76%$0.96$0.8742,419 shs$30.25 million04/17/2024$0.92$0.92-0.51%$0.93$0.8924,277 shs$31.76 million04/16/2024$0.91$0.92+1.27%$0.94$0.8941,947 shs$31.92 million04/15/2024$0.98$0.91-7.74%$1.02$0.8976,569 shs$31.53 millionNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for Free (Ad)Optimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analysis meets hedge fund-level market foresight!TRY "INVESTING IDEAS" TODAY04/12/2024$1.02$0.98-3.46%$1.03$0.9762,500 shs$34.17 million04/11/2024$1.00$1.02+2.00%$1.05$0.9823,757 shs$35.39 million04/10/2024$1.01$1.00-0.99%$1.11$0.9867,752 shs$34.70 million04/09/2024$1.32$1.01-23.48%$1.37$0.98410,810 shs$35.05 million04/08/2024$1.56$1.32-15.38%$1.58$1.21458,124 shs$45.80 million04/05/2024$1.34$1.56+16.42%$1.90$1.341.52 million shs$54.13 million04/04/2024$0.96$1.34+38.89%$1.35$0.94765,001 shs$46.50 million04/03/2024$0.94$0.96+2.64%$0.98$0.9358,319 shs$33.48 million04/02/2024$0.95$0.94-0.88%$0.96$0.9135,535 shs$32.62 million04/01/2024$0.91$0.95+4.40%$0.95$0.9136,107 shs$32.91 million03/29/2024$0.91$0.91$0.93$0.9035,116 shs$31.52 million03/28/2024$0.91$0.91-0.19%$0.93$0.9035,063 shs$31.52 million03/27/2024$0.94$0.91-2.99%$0.93$0.9134,109 shs$31.58 million03/26/2024$0.92$0.94+1.96%$0.94$0.9035,831 shs$32.55 million03/25/2024$0.87$0.92+5.75%$0.92$0.8744,343 shs$31.92 million03/22/2024$0.89$0.87-2.25%$0.89$0.8732,131 shs$30.03 million03/21/2024$0.90$0.89-0.67%$0.91$0.8646,506 shs$30.72 million03/20/2024$0.86$0.90+4.19%$0.91$0.7866,272 shs$30.93 million03/19/2024$0.86$0.86$0.91$0.8518,941 shs$29.69 million03/18/2024$0.89$0.86-3.86%$0.91$0.8638,118 shs$29.69 million03/15/2024$0.89$0.89+0.51%$0.91$0.8138,273 shs$30.88 million03/14/2024$0.91$0.89-2.20%$0.92$0.82143,886 shs$30.72 million03/13/2024$0.91$0.91-0.22%$0.95$0.9051,739 shs$31.41 million03/12/2024$0.95$0.91-3.96%$0.97$0.9125,945 shs$31.48 million03/11/2024$0.96$0.95-1.29%$0.99$0.9050,188 shs$32.78 million03/08/2024$0.93$0.96+3.33%$0.97$0.9222,834 shs$33.21 million03/07/2024$0.98$0.93-4.61%$0.98$0.9343,887 shs$32.14 million Related Companies: Celularity Stock Chart Adicet Bio Stock Chart Cardiff Oncology Stock Chart aTyr Pharma Stock Chart Sangamo Therapeutics Stock Chart DBV Technologies Stock Chart bluebird bio Stock Chart Omega Therapeutics Stock Chart Athira Pharma Stock Chart Vigil Neuroscience Stock Chart Receive INKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for MiNK Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INKT) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredShocking $16T Elon Musk Crypto LeakReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto mark...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiNK Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MiNK Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.